CurrentCardio
Get Weekly

CurrentCardio coverage · page 2 of 11

JACC: Cardiovascular Interventions

Briefs 41–80 of 433 CurrentCardio has covered from this journal, newest publication first

Latest from JACC: Cardiovascular Interventions

All coverage, newest first

  1. JACC Cardiovasc Interv

    Redo-TAVR (TAV-in-TAV) Best Practices Part 2: Tall-in-Short and Tall-in-Tall: A Heart and Valve Collaboratory Document

    Guideline or statementValvular & structural

  2. JACC Cardiovasc Interv

    Leaflet Modification to Mitigate Coronary Obstruction Risk During TAVR: Results From the LOFTER-TAVR Registry

    Cohort studyValvular & structural

  3. JACC Cardiovasc Interv

    Mitral Valve Leaflet Modification: A Working Group Position Statement on Best Practices and Step-by-Step Guide

    Research articleValvular & structural

  4. JACC Cardiovasc Interv

    UNICORN During Transcatheter Aortic Valve Replacement in Native and Bioprosthetic Aortic Valves: A Multicenter Study

    Cohort studyValvular & structural

  5. JACC Cardiovasc Interv

    Impact of Leaflet Modification on the Occurrence of Hypoattenuated Leaflet Thickening After Valve-in-Valve Transcatheter Aortic Valve Replacement

    Cohort studyValvular & structural

  6. JACC Cardiovasc Interv

    Leaflet Splitting to Prevent TAVR-Induced Coronary Obstruction in Stented vs Stentless Surgical Bioprosthetic Valves

    Cohort studyValvular & structural

  7. JACC Cardiovasc Interv

    Characteristics of Coronary Intra- or Extramedial Hematomas Causing Emergent Return to Catheterization Laboratory After Percutaneous Coronary Intervention

    Cohort studyCoronary & ACS

  8. JACC Cardiovasc Interv

    Coronary Stenosis Location, Revascularization Strategy, and Sudden Cardiac Death in Chronic and Acute Coronary Syndromes

    Cohort studyCoronary & ACS

  9. JACC Cardiovasc Interv

    Impact of Coronary Artery Disease and Revascularization on Outcomes After Transcatheter Tricuspid Edge-to-Edge Repair

    Cohort studyValvular & structural

  10. JACC Cardiovasc Interv

    Oral Anticoagulation With or Without Antiplatelet Therapy in Chronic Coronary Syndrome: A Meta-Analysis of Randomized Trials

    Meta-analysisCoronary & ACS

  11. JACC Cardiovasc Interv

    Predictors of Procedural and Clinical Outcomes Following Transcatheter Tricuspid Edge-to-Edge Repair: An Expert Overview

    Meta-analysisValvular & structural

  12. JACC Cardiovasc Interv

    Drug-Coated Balloon–Based Angioplasty for Chronic Total Occlusions: The PICCOLETO X Study

    Cohort studyCoronary & ACS

  13. JACC Cardiovasc Interv

    Balloon-Assisted Translocation of the Mitral Anterior Leaflet to Prevent Outflow Tract Obstruction During TMVR: The BATMAN Registry

    Cohort studyValvular & structural

  14. JACC Cardiovasc Interv

    Clinical Outcomes of Transfemoral Transcatheter Mitral Valve Replacement: Results From the CHOICE-MI Registry

    Cohort studyValvular & structural

  15. JACC Cardiovasc Interv

    1-Year Real-World Outcomes With the Amulet Occluder From the EMERGE LAA Postapproval Study

    Cohort studyArrhythmias & EP

  16. JACC Cardiovasc Interv

    30-Day Outcomes of a Single-Stage Transfemoral Mitral Valve Replacement System in Severe Mitral Valve Disease

    Research articleValvular & structural

  17. JACC Cardiovasc Interv

    Long-Term Outcomes in Patients With New-Onset Left Bundle Branch Block Following TAVR

    Cohort studyValvular & structural

  18. JACC Cardiovasc Interv

    Effect of Sublingual Nitroglycerin on Absolute Coronary Blood Flow: A Randomized Double-Blind Placebo-Controlled Mechanistic Study

    Randomised controlled trialCoronary & ACS

  19. JACC Cardiovasc Interv

    Pulmonary Artery Pulsatility Index and Clinical Outcomes in Patients Undergoing Transcatheter Tricuspid Valve Replacement

    Cohort studyValvular & structural

  20. JACC Cardiovasc Interv

    Balloon Pulmonary Angioplasty for Treatment of Chronic Thromboembolic Pulmonary Hypertension: Statement From the BPA-CTEPH Alliance

    Guideline or statementPulmonary vascular & VTE

  21. JACC Cardiovasc Interv

    Cold Laser vs Excimer Laser in Lower Limb Atherosclerosis: A Prospective Multicenter Randomized Trial

    Randomised controlled trial

  22. JACC Cardiovasc Interv

    Relative Fractional Flow Reserve Increase and Final Fractional Flow Reserve After Percutaneous Coronary Intervention

    Cohort studyCoronary & ACS

  23. JACC Cardiovasc Interv

    Side Branch Additional Treatment for Coronary Bifurcation Lesion Revascularization: Insights From the KISS Randomized Trial

    Randomised controlled trialCoronary & ACS

  24. JACC Cardiovasc Interv

    Transmitral Gradients and Mortality Following Transseptal Transcatheter Mitral Valve in Valve

    Cohort studyValvular & structural

  25. JACC Cardiovasc Interv

    Applying the 2025 ESC/EACTS Recommendations for the Treatment of Severe Tricuspid Regurgitation to Real-World Practice

    Cohort studyValvular & structural

  26. JACC Cardiovasc Interv

    Frequency and Outcomes of Acute Hemodynamic Instability Following Transcatheter Tricuspid Valve Replacement: Insights From the CESAR-TR-Registry

    Cohort studyValvular & structural

  27. JACC Cardiovasc Interv

    Incidence, Clinical Implications, and Predictors of Paravalvular Leak Following Transcatheter Tricuspid Valve Replacement: The TRIPLACE Registry

    Cohort studyValvular & structural

  28. JACC Cardiovasc Interv

    Incidence, Predictors and Outcomes of Bleeding Following Transcatheter Tricuspid Valve Repair: The TriValve Registry

    Cohort studyValvular & structural

  29. JACC Cardiovasc Interv

    Management and Outcome of Failed Transcatheter Tricuspid Edge-to-Edge Repair: Insights From the FATE International Registry

    Cohort studyValvular & structural

  30. JACC Cardiovasc Interv

    Prognostic Value of Microvascular Resistance Reserve in Coronary Artery Disease: A Systematic Review and Meta-Analysis

    Meta-analysisCoronary & ACS

  31. JACC Cardiovasc Interv

    Durability of Mitral Valve Transcatheter Edge-to-Edge Repair: An Expert Overview

    Meta-analysisValvular & structural

  32. JACC Cardiovasc Interv

    Nonfatal Adverse Events and Risk for Subsequent Mortality in Patients Undergoing Percutaneous Coronary Intervention

    Cohort studyCoronary & ACS

  33. JACC Cardiovasc Interv

    Contemporary Trends, Characteristics, and Outcomes of Patients Undergoing Percutaneous Coronary Intervention for Stent Thrombosis

    Cohort studyCoronary & ACS

  34. JACC Cardiovasc Interv

    Predicting Outcomes in Patients With Tricuspid Regurgitation Undergoing Transcatheter Edge-to-Edge Repair Using an Artificial Intelligence–Derived Risk Score: The EuroTR Risk Score

    Diagnostic or prognostic studyValvular & structural

  35. JACC Cardiovasc Interv

    Prognostic Value of NT-proBNP in Patients Undergoing Tricuspid Valve Transcatheter Edge-to-Edge Repair: The EuroTR Registry

    Cohort studyValvular & structural

  36. JACC Cardiovasc Interv

    Fibrotic Tissue Ingrowth of Transcatheter Heart Valve Frames

    Research articleValvular & structural

  37. JACC Cardiovasc Interv

    Major Bleeding Risk Assessment With Atrial Fibrillation Post-TAVR: The HARHP Score Results From ENVISAGE-TAVI AF

    Secondary analysisArrhythmias & EP

  38. JACC Cardiovasc Interv

    Right Ventricular to Pulmonary Arterial Uncoupling Is Associated With 1-Year Mortality in ST-Segment Elevation Myocardial Infarction

    Secondary analysisCoronary & ACS

  39. JACC Cardiovasc Interv

    Predictors of Left Atrial Compliance and V-Wave Response in Patients Undergoing Transcatheter Mitral Valve Therapy

    Cohort studyValvular & structural

  40. JACC Cardiovasc Interv

    Intravascular Lithotripsy or Mechanical Debulking in Complex Calcified Coronary Arteries: Multicenter, Prospective ROLLING STONE Study

    Cohort studyCoronary & ACS

All 433 Briefs in ExploreShowing Briefs 41–80 of 433, newest first